Fennec Pharmaceuticals Inc.
FENCCIK 0001211583 · last filing Jul 2, 2026
Insider signal
trades dated in the last 90 days · non-derivative only
21,729 bought / 9,599 sold
net +12,130 sh · −$61.7K
- buys
- 7
- sells
- 1
- insiders active
- 6
Filing tape
Filed Thu, Jul 2, 2026
- +8,776 sh · $61.7K
- Granted2,778Common shares→ 132,857 held
- Exercised15,597Common shares@ $2.45→ 148,454 held
- Sold9,599Common shares@ $10.41→ 138,855 held
- Exercised15,597Stock Options@ $2.45→ 1,525,000 held
Filed Wed, Jul 1, 2026
- +156 sh
Cioffi Christiana Marie — Chief Strategy Officer
- Granted156Common shares→ 24,332 held
- +168 sh
Sayad Pierre Sargis — Chief Medical Officer
- Granted168Common Shares→ 21,183 held
- +168 sh
Evans Terry L — Chief Commercial Officer
- Granted168Common Shares→ 21,183 held
- +1,159 sh
Hackman Jeffrey S. — Chief Executive Officer · Director
- Granted1,159Common Shares→ 63,984 held
- +1,703 sh
Andrade Robert — CHIEF FINANCIAL OFFICER
- Granted1,703Common shares→ 290,972 held
Insiders on this tape
- Raykov Rosty
- Cioffi Christiana MarieChief Strategy Officer
- Sayad Pierre SargisChief Medical Officer
- Evans Terry LChief Commercial Officer
- Hackman Jeffrey S.Chief Executive Officer · Director
- Andrade RobertCHIEF FINANCIAL OFFICER
Informational data only — not investment advice.
The institutional holdings shown here are aggregated from third-party public regulatory filings (such as SEC Form 13F). These filings are reported with a delay (generally up to 45 days after each quarter-end), are backward-looking, and may exclude short positions, non-U.S. holdings, cash, and other assets. The data may contain errors, omissions, misclassifications, or gaps, and may not reflect a manager's current positions.
All figures are provided on an "as is" basis for general information only. Nothing on this page is financial, investment, or trading advice, a recommendation, or an endorsement of any security, manager, or strategy. Do not rely on it. Independently verify any figure against the original filings and consult a qualified professional before making any financial decision. Your use is subject to our Terms of Service.